You are here

Article Text

Article menu
Download PDFPDF
Letter
Glucagon use in β blocker overdose
  1. Niall O’Connor1,
  2. Shaun Greene2,
  3. Paul Dargan3,
  4. Alison Jones3
  1. 1Our Lady of Lourdes Hospital, Drogheda, Ireland
  2. 2Emergency Department, Guys and St Thomas’ NHS Trust
  3. 3National Poisons Information Service, Guys and St Thomas’ NHS Trust
  1. Correspondence to:
 Niall O’Connor
 niall.oconnormaile.hse.ie

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    The Best Evidence Topic Reports series is intended to provide evidence-based answers to clinical questions. The recent best evidence topic report by Boyd1 concluded that there is not enough evidence to support the use of glucagon in β blocker overdose. However, clinical toxicology is an area in which the evidence basis is …

    View Full Text